Bio-Rad Laboratories | BIO - Ebitda

Aktienkurs
287.84
Täglich Wechseln
6.42 2.28%
Monatlich
5.20%
Jährlich
18.77%
Q2 Prognose
281.68




Ebitda Veränderung Datum
Abbott USD 3.27B 178M 2025-12
Agilent USD 540M 74M 2025-09
Becton, Dickinson and Co. USD 1.71B 433M 2025-12
Bio Techne USD 103.42M 7.47M 2025-12
Bio-Rad Laboratories USD -374.6M 841.8M 2025-09
Bruker USD 211.6M 207.4M 2025-12
Charles River Laboratories USD 258.06M 24.83M 2025-12
Danaher USD 1.92B 204M 2026-03
General Electric Aerospace USD 2.84B 568M 2026-03
Illumina USD 332M 12M 2025-09
IQVIA Holdings USD 1.05B 97M 2025-12
Laboratory Of America USD 588.1M 24.1M 2025-12
Merck USD 8.39B 1.97B 2025-09
Mettler Toledo International USD 322.64M 26.75M 2025-09
Myriad Genetics USD 14.3M 4M 2025-12
OraSure Technologies USD -17.7M 4.06M 2025-12
Pacific Biosciences Of California USD -35.4M 5.78M 2025-09
Quest Diagnostics USD 557M 20M 2026-03
Repligen USD 39.54M 3.61M 2025-12
Revvity USD 248.91M 48.52M 2025-12
Roche Holding CHF 12.68B 2.36B 2024-06
Siemens EUR 3.64B 535M 2025-12
Standard Biotools USD -15.81M 734K 2025-12
Thermo Fisher Scientific USD 2.7B 464M 2026-03
Tosoh JPY 39.13B 286M 2024-12
Waters USD 380.97M 85.83M 2025-12